Dr. Reddy’s Proposed Rituximab Biosimilar Application Accepted for Review by USFDA, EMA and MHRA

Dr. Reddy's Laboratories Ltd., a global pharmaceutical company based in Hyderabad, India, has reached a significant milestone in its pursuit of bringing a biosimilar rituximab to market. The company's proposal for the rituximab biosimilar, known as DRL_RI, has been accepted for review by multiple regulatory agencies. &nbsp In January 2023, Dr. Reddy's Laboratories announced the successful comple..